| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $186.7M | — | +11.1% |
| Cost of Revenue | $105.8M | — | +11.6% |
| Gross Profit | $80.9M | — | +10.4% |
| R&D Expense | $9.5M | — | -6.4% |
| SG&A Expense | $65.7M | — | -3.6% |
| Operating Income | -$18.2M | — | +34.4% |
| Pre-tax Income | -$17.6M | — | +31.5% |
| Income Tax | -$472K | — | -277.4% |
| Net Income | -$17.1M | — | +34.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $146.1M | -8.4% | -57.8% |
| Accounts Receivable | $167.4M | +5.1% | +10.7% |
| Inventory | $29.8M | +4.4% | +0.2% |
| Current Assets | $373.7M | -0.7% | -34.9% |
| Total Assets | $1.35B | -1.0% | -15.9% |
| Current Liabilities | $84.6M | -4.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.1M | — | +67.9% |
| Capital Expenditures | $5.0M | — | +11.1% |
| Investing Cash Flow | -$5.0M | — | -240.4% |
| Financing Cash Flow | -$338K | — | -135.6% |
| Free Cash Flow | -$13.1M | — | +56.0% |
| -69.8% |
| Total Liabilities | $517.8M | -1.1% | -27.4% |
| Stockholders' Equity | $828.8M | -0.9% | -6.7% |